eli-lilly | iCloud.Info

eli-lilly

Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker

Fri, 01/03/2025 - 05:00

Tech Insider : Business

Red pills with $100 bills wrapped around them. — Chris Roop, head of M&A for the Americas at investment bank Jefferies, said Big Pharma will be looking for new drugs to boost growth in 2025.
GP Kidd/Getty Images

Tech, Healthcare, Startups, big-pharma, biopharma, Biotech, keytruda

5 new weight-loss drugs to watch in the fight for the next Ozempic

Sat, 11/16/2024 - 05:47

A pill — The race is on to make a weight-loss pill that is as effective as injectables like Ozempic, Wegovy, Mounjaro, and Zepbound.
Getty Images

health, health, weight-loss, GLP-1, semaglutide, vk-2735, eli-lilly

Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.

Thu, 09/26/2024 - 18:02

Portrait image of Tara Rothenhoefer — Tara Rothenhoefer has been taking tirzepatide for more than four years, and only in the past six months has she felt secure in having an affordable supply.
Octavio Jones for BI

health, health, weight-loss, GLP-1, compounded-glp-1, tirzepatide, mounjaro

Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs

Tue, 08/27/2024 - 10:11

A close up of a person injecting a medication into their stomach — Popular weight loss medication tirzepatide, sold as Zepbound, will now be available at a steep discount from manufacturer Eli Lilly, in an attempt to fight back against cheap knock-off versions of the drug.
Tassii/Getty Images

health, health, weight-loss, tirzepatide, eli-lilly, zepbound, GLP-1

Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question

Tue, 08/20/2024 - 11:17

mounjaro tirzepatide pen — Sandy Huffaker for The Washington Post via Getty Images

health, tirzepatide, GLP-1, zepbound, eli-lilly, mounjaro

Google's new CFO Anat Ashkenazi raked in a nearly $10 million signing bonus

Sat, 06/08/2024 - 20:25

Google campus located in California — Google's parent company, Alphabet, on Wednesday announced the appointment of its new CFO, former Eli Lilly executive Anat Ashkenazi.
Melina Mara/The Washington Post via Getty Images

Tech, insider-news, eli-lilly, google, anat-ashkenazi, cfo

Eli Lilly's Wegovy rival Zepbound will help make weight-loss drug market worth $130 billion by 2030, Goldman Sachs says

Sun, 06/02/2024 - 00:02

Zepbound — Zepbound is Eli Lilly's new weight-loss drug.
Brendan McDermid/Reuters

health, finance, health, finance, Ozempic, eli-lilly, novo-nordisk

A Gen Z diabetic said a 3-month supply of insulin pumps would cost her $1,800 — even with insurance

Wed, 02/07/2024 - 09:32

Tech Insider : Economy, Economy

Grace stands in her scrubs with a stethoscope around her shoulders. — Grace Cochran, 25, is a nurse in Charlotte, North Carolina. On her TikTok account, she share her experience navigating the healthcare system as a Type 1 diabetic.
Grace Cochran

economy, Healthcare, economy, Healthcare, insulin, insulin-prices, insulin-price-cap

Healthcare companies are promising to help patients quit Wegovy. There's just one problem with that.

Tue, 12/19/2023 - 05:57

Illustration of person and Ozempic pen. — Cornelia Li for Business Insider

Healthcare, health, wegovy, Ozempic, zepbound, GLP-1, weight-loss

Ozempic maker plans manufacturing blitz as market for the drug is expected to top $100 billion in 2030

Thu, 11/23/2023 - 17:08

woman holding ozempic pen — Getty Images

Healthcare, Ozempic, wegovy, novo-nordisk, eli-lilly

Subscribe to eli-lilly